The intramolecular ligand-exchange reaction of (SP-4-2)-dichlorobis-(2-hydroxyethylamine)platinum(II) and (OC-6-22)-tetrachlorobis-(2-hydroxyethylamine)platinum(IV), a 1H and 15N,1H-HMQC NMR study

European Journal of Inorganic Chemistry

Volumn , Issue 5, 2001, Pages 1145-1149

  Galanski, Markus ^a   Zimmermann, Wolfgang ^a   Baumgartner, Christian ^a   Keppler, Bernhard Klaus ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Ligand exchange; N ligands; NMR spectroscopy; Platinum; X ray diffraction

Indexed keywords

CRYSTAL STRUCTURE; LIGANDS; PLATINUM COMPOUNDS; SYNTHESIS (CHEMICAL); X RAY DIFFRACTION;

1-FORMS; LIGAND EXCHANGE REACTIONS; LIGAND EXCHANGES; N LIGANDS; N-LIGANDS; NMR STUDIES; NMR-SPECTROSCOPY; PLATINUM COMPLEXES; SYNTHESISED; X- RAY DIFFRACTIONS;

NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

CHLORO(2 ETHANOLATOAMINE KAPPA 2 N,O)(2 HYDROXYETHYLAMINE)PLATINUM; DICHLOROBIS(2 HYDROXYETHYLAMINE)PLATINUM; ETHANOLAMINE DERIVATIVE; GUANOSINE PHOSPHATE; LIGAND; PLATINUM COMPLEX; PLATINUM DERIVATIVE; TETRACHLOROBIS(2 HYDROXYETHYLAMINE)PLATINUM; TRICHLORO(2 ETHANOLATOAMINE KAPPA 2 N,O)(2 HYDROXYETHYLAMINE)PLATINUM; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CHEMICAL REACTION; CRYSTAL STRUCTURE; DRUG STRUCTURE; DRUG SYNTHESIS; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

EID: 0035049895     PISSN: 14341948     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-0682(200105)2001:5<1145::AID-EJIC1145>3.0.CO;2-E     Document Type: Article

References (16)

1. B. Rosenberg, Interdiscip. Sci. Rev. 1978, 3, 134.
2. Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug (Ed.: B. Lippert), Weinheim, Wiley-VCH, 1999.
3. M. C. Christian, Semin. Oncol. 1992, 19, 720.
4. D. D. Von Hoff, R. Schilsky, C. M. Reichert, R. L. Reeddick, R. C. Young, F. M. Muggia, Cancer Treat. Rep. 1979, 63 1527.
5. R. B. Weiss, M. C. Christian, Drugs 1993, 46, 360.
6. L. R. Kelland, S. J. Clarke, M. J. McKeage, Platinum Metals Rev. 1992, 36, 178.
7. L. R. Kelland, Crit. Rev. Oncol. Hematol. 1993, 15, 191.
8. E. Wong, C. M. Giandomenico, Chem. Rev. 1999, 99, 2451
9. W. Zimmermann, M. Galanski, B. K. Keppler, in Relevance of Tumor Models for Anticancer Drug Development (Eds.: H. H. Fiebig, A. M. Burger), Contrib. Oncol. Basel, Karger 1999, 54, 447.
10. J. Reedijk, Inorg. Chim. Acta 1992, 198/200, 873.
11. E. R. Jamieson, S. J. Lippard, Chem. Rev. 1999, 99, 2467.
12. A. Zenker, M. Galanski, T. L. Bereuter, B. K. Keppler, W. Lindner, J. Biol. Inorg. Chem. in press.
13. W. Zimmermann, M. Galanski, G. Giesster, B. K. Keppler, Inorg. Chim. Acta 1999, 292, 127.
14. Crystallographic data (excluding structure factors) for the structure reported in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication no. CCDC-132673. Copies of the data can be obtained free of charge on application to CCDC, 12 Union Road, Cambridge CB 1EZ, UK [Fax: (internat.) +44-1223/336-033; E-mail: deposit@ccdc.cam.ac.uk.
15. G. M. Sheldrick, SHELXS-97, University of Göttingen, 1997.
16. G. M. Sheldrick, SHELXL-97, University of Göttingen, 1997.